Search results
Taysha Gene Therapies Inc (TSHA) receives an Overweight rating from Piper Sandler – Knox Daily
Knox Daily· 3 days agoAs a result of the transaction, Manning Paul B now holds 16,466,667 shares, worth roughly $39.36 million. Piper Sandler initiated its Taysha Gene Therapies Inc [TSHA] rating ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 1 day agoGenprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, will ...
These Are The 5 Best Stocks To Buy And Watch Now
Investor's Business Daily· 9 hours agoBuying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So which are the best stocks to buy now or put on a...
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
InvestorPlace· 18 hours agoPay close attention to gene editing stocks. All in an effort to help treat sickle-cell anemia,...
Think You Need A Good Stock? Look At This Taysha Gene Therapies Inc
Stocks Register· 2 days agoThe beta value is 0.32, while the average true range (ATR) is currently pointing at 0.25. Coming back to Taysha Gene Therapies Inc (NASDAQ:TSHA), we note
Earnings call: Avid Bioservices sees revenue boost, optimistic on growth
Investing.com· 3 days agoDespite this quarterly rise, the company observed a decrease in revenues compared to the same...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Benzinga via Yahoo Finance· 6 days agoFriday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate...
Agathos Biologics aims for ethical solutions in gene therapy, including morally derived vaccines
The Fargo Forum· 5 days agoFor Andrzej Noyszewski, the most mundane drive to work often elicits a deep sense of gratitude....
Earnings call: Avid Bioservices sees revenue boost, optimistic on growth By Investing.com
Investing.com· 3 days agoDespite this quarterly rise, the company observed a decrease in revenues compared to the same...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia - Pfizer (NYSE:PFE)
Benzinga· 6 days agoFriday, the FDA approved Pfizer Inc’s PFE Beqvez (fidanacogene elaparvovec-dzkt) for moderate to...